Corbus Pharmaceuticals Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRBP research report →
About the company
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity.
- CEO
- Yuval Cohen
- IPO
- 2014
- Employees
- 36
- HQ
- Norwood, MA, US
Price Chart
- Market Cap
- $115.95M
- P/E
- -1.40
- P/S
- 0.00
- P/B
- 0.97
- EV/EBITDA
- -1.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -70.89%
- ROIC
- -70.44%
- Revenue
- $0 · 0.00%
- Net Income
- $-78,537,000 · -95.32%
- EPS
- $-5.90 · -60.33%
- Op Income
- $-85,310,000
- FCF YoY
- -54.32%
- 52W High
- $20.56
- 52W Low
- $7.12
- 50D MA
- $9.27
- 200D MA
- $10.19
- Beta
- 2.56
- Avg Volume
- 488.85K
Get TickerSpark's AI analysis on CRBP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Kung Winston | sell | 2,026 |
| Jun 10, 26 | Altmeyer Anne | sell | 2,412 |
| Jun 10, 26 | Jenkins John Kenneth | sell | 4,800 |
| Jun 3, 26 | Saxena Nishant C | buy | 9,000 |
| Jun 2, 26 | Saxena Nishant C | buy | 4,500 |
| May 21, 26 | Saxena Nishant C | other | 192,300 |
| May 21, 26 | Saxena Nishant C | other | 58,300 |
| May 21, 26 | Saxena Nishant C | other | 0 |
| May 19, 26 | Kung Winston | other | 3,800 |
| May 19, 26 | Kung Winston | other | 12,300 |
Our CRBP coverage
Recent articles, reports, and earnings notes.
No research on CRBP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRBP report →Similar companies
Peers in the same neighborhood.